131 related articles for article (PubMed ID: 37989651)
1. Translational research for the development of treatment of patients with neurogenetic diseases: An important step for Angelman syndrome.
Dan B
Eur J Paediatr Neurol; 2023 Nov; 47():A2. PubMed ID: 37989651
[No Abstract] [Full Text] [Related]
2. Sleep Disorders in Childhood Neurogenetic Disorders.
Dosier LBM; Vaughn BV; Fan Z
Children (Basel); 2017 Sep; 4(9):. PubMed ID: 28895939
[TBL] [Abstract][Full Text] [Related]
3. [Neurogenetic dialogue illustrated by the "pantin hilare" of angelman syndrome].
Dan B
Bull Mem Acad R Med Belg; 2010; 165(7-9):327-33; discussion 334-7. PubMed ID: 21513093
[TBL] [Abstract][Full Text] [Related]
4. The Road to Personalized Therapies: Lessons Learned From Angelman Syndrome.
Duis J
Am J Intellect Dev Disabil; 2022 Mar; 127(2):95-98. PubMed ID: 35180775
[TBL] [Abstract][Full Text] [Related]
5. Neurogenetic disorders and treatment of associated seizures.
Faulkner MA; Singh SP
Pharmacotherapy; 2013 Mar; 33(3):330-43. PubMed ID: 23400943
[TBL] [Abstract][Full Text] [Related]
6. Stimulant intolerance in children with Angelman syndrome with hyperactivity: a case series.
Keary CJ; Thom RP; McDougle CJ
Psychiatr Genet; 2022 Apr; 32(2):80-86. PubMed ID: 35348128
[TBL] [Abstract][Full Text] [Related]
7. Angelman syndrome - insights into a rare neurogenetic disorder.
Buiting K; Williams C; Horsthemke B
Nat Rev Neurol; 2016 Oct; 12(10):584-93. PubMed ID: 27615419
[TBL] [Abstract][Full Text] [Related]
8. Neurologic manifestations of Angelman syndrome.
Thibert RL; Larson AM; Hsieh DT; Raby AR; Thiele EA
Pediatr Neurol; 2013 Apr; 48(4):271-9. PubMed ID: 23498559
[TBL] [Abstract][Full Text] [Related]
9. Distinctive pattern of behavioral functioning in Angelman syndrome.
Summers JA; Feldman MA
Am J Ment Retard; 1999 Jul; 104(4):376-84. PubMed ID: 10450464
[TBL] [Abstract][Full Text] [Related]
10. An ASO therapy for Angelman syndrome that targets an evolutionarily conserved region at the start of the
Dindot SV; Christian S; Murphy WJ; Berent A; Panagoulias J; Schlafer A; Ballard J; Radeva K; Robinson R; Myers L; Jepp T; Shaheen H; Hillman P; Konganti K; Hillhouse A; Bredemeyer KR; Black L; Douville J; ;
Sci Transl Med; 2023 Mar; 15(688):eabf4077. PubMed ID: 36947593
[TBL] [Abstract][Full Text] [Related]
11. [Neuropsychiatric phenotype of Angelman syndrome and clinical care: report of seven cases].
Cote-Orozco JE; Mera-Solarte PD; Espinosa-García E
Arch Argent Pediatr; 2017 Apr; 115(2):e99-e103. PubMed ID: 28318193
[TBL] [Abstract][Full Text] [Related]
12. Excessive Laughter-like Vocalizations, Microcephaly, and Translational Outcomes in the
Berg EL; Jami SA; Petkova SP; Berz A; Fenton TA; Lerch JP; Segal DJ; Gray JA; Ellegood J; Wöhr M; Silverman JL
J Neurosci; 2021 Oct; 41(42):8801-8814. PubMed ID: 34475199
[TBL] [Abstract][Full Text] [Related]
13. Alterations in white matter pathways in Angelman syndrome.
Peters SU; Kaufmann WE; Bacino CA; Anderson AW; Adapa P; Chu Z; Yallampalli R; Traipe E; Hunter JV; Wilde EA
Dev Med Child Neurol; 2011 Apr; 53(4):361-7. PubMed ID: 21121904
[TBL] [Abstract][Full Text] [Related]
14. Dental treatment in Angelman syndrome patients. 8 case reports.
Gallo C; Marcato A; Beghetto M; Stellini E
Eur J Paediatr Dent; 2012 Dec; 13(4):345-8. PubMed ID: 23270298
[TBL] [Abstract][Full Text] [Related]
15. Angelman syndrome and thyroid dysfunction.
Monterrubio-Ledezma CE; Bobadilla-Morales L; Pimentel-Gutiérrez HJ; Corona-Rivera JR; Corona-Rivera A
Genet Couns; 2012; 23(3):353-7. PubMed ID: 23072182
[TBL] [Abstract][Full Text] [Related]
16. Sleep phenotypes in infants and toddlers with neurogenetic syndromes.
Abel EA; Tonnsen BL
Sleep Med; 2017 Oct; 38():130-134. PubMed ID: 29031747
[TBL] [Abstract][Full Text] [Related]
17. Effects of environmental events on smiling and laughing behavior in Angelman syndrome.
Oliver C; Demetriades L; Hall S
Am J Ment Retard; 2002 May; 107(3):194-200. PubMed ID: 11966332
[TBL] [Abstract][Full Text] [Related]
18. Early detection of Angelman syndrome resulting from de novo paternal isodisomic 15q UPD and review of comparable cases.
Horváth E; Horváth Z; Isaszegi D; Gergev G; Nagy N; Szabó J; Sztriha L; Széll M; Endreffy E
Mol Cytogenet; 2013 Sep; 6(1):35. PubMed ID: 24011290
[TBL] [Abstract][Full Text] [Related]
19. Using generalizability theory to evaluate the comparative reliability of developmental measures in neurogenetic syndrome and low-risk populations.
Hamrick LR; Haney AM; Kelleher BL; Lane SP
J Neurodev Disord; 2020 Jun; 12(1):16. PubMed ID: 32503425
[TBL] [Abstract][Full Text] [Related]
20. [Angelman syndrome: clinical and genetic model].
Dan B; Chéron G
Rev Neurol (Paris); 2003 May; 159(5 Pt 1):499-510. PubMed ID: 12773895
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]